191 related articles for article (PubMed ID: 7777193)
1. Increased cerebrospinal fluid tau in patients with Alzheimer's disease.
Jensen M; Basun H; Lannfelt L
Neurosci Lett; 1995 Feb; 186(2-3):189-91. PubMed ID: 7777193
[TBL] [Abstract][Full Text] [Related]
2. Cerebrospinal fluid {beta}-amyloid 42 and tau proteins as biomarkers of Alzheimer-type pathologic changes in the brain.
Tapiola T; Alafuzoff I; Herukka SK; Parkkinen L; Hartikainen P; Soininen H; Pirttilä T
Arch Neurol; 2009 Mar; 66(3):382-9. PubMed ID: 19273758
[TBL] [Abstract][Full Text] [Related]
3. Decreased beta-amyloid1-42 and increased tau levels in cerebrospinal fluid of patients with Alzheimer disease.
Sunderland T; Linker G; Mirza N; Putnam KT; Friedman DL; Kimmel LH; Bergeson J; Manetti GJ; Zimmermann M; Tang B; Bartko JJ; Cohen RM
JAMA; 2003 Apr 23-30; 289(16):2094-103. PubMed ID: 12709467
[TBL] [Abstract][Full Text] [Related]
4. Cerebrospinal fluid beta-amyloid1-42 and tau in control subjects at risk for Alzheimer's disease: the effect of APOE epsilon4 allele.
Sunderland T; Mirza N; Putnam KT; Linker G; Bhupali D; Durham R; Soares H; Kimmel L; Friedman D; Bergeson J; Csako G; Levy JA; Bartko JJ; Cohen RM
Biol Psychiatry; 2004 Nov; 56(9):670-6. PubMed ID: 15522251
[TBL] [Abstract][Full Text] [Related]
5. Cerebrospinal fluid markers for Alzheimer's disease in a cognitively healthy cohort of young and old adults.
Paternicò D; Galluzzi S; Drago V; Bocchio-Chiavetto L; Zanardini R; Pedrini L; Baronio M; Amicucci G; Frisoni GB
Alzheimers Dement; 2012 Nov; 8(6):520-7. PubMed ID: 22677492
[TBL] [Abstract][Full Text] [Related]
6. Proteomic analysis of cerebrospinal fluid in Alzheimer's disease: wanted dead or alive.
Oláh Z; Kálmán J; Tóth ME; Zvara Á; Sántha M; Ivitz E; Janka Z; Pákáski M
J Alzheimers Dis; 2015; 44(4):1303-12. PubMed ID: 25428253
[TBL] [Abstract][Full Text] [Related]
7. Increased cerebrospinal fluid levels of double-stranded RNA-dependant protein kinase in Alzheimer's disease.
Mouton-Liger F; Paquet C; Dumurgier J; Lapalus P; Gray F; Laplanche JL; Hugon J;
Biol Psychiatry; 2012 May; 71(9):829-35. PubMed ID: 22281122
[TBL] [Abstract][Full Text] [Related]
8. Comprehensive Quantitative Profiling of Tau and Phosphorylated Tau Peptides in Cerebrospinal Fluid by Mass Spectrometry Provides New Biomarker Candidates.
Russell CL; Mitra V; Hansson K; Blennow K; Gobom J; Zetterberg H; Hiltunen M; Ward M; Pike I
J Alzheimers Dis; 2017; 55(1):303-313. PubMed ID: 27636850
[TBL] [Abstract][Full Text] [Related]
9. Validation of a prototype tau Thr231 phosphorylation CSF ELISA as a potential biomarker for Alzheimer's disease.
Santos JRF; Bauer C; Schuchhardt J; Wedekind D; Waniek K; Lachmann I; Wiltfang J; Vogelgsang J
J Neural Transm (Vienna); 2019 Mar; 126(3):339-348. PubMed ID: 30767082
[TBL] [Abstract][Full Text] [Related]
10. Alzheimer's Disease-Associated Cerebrospinal Fluid (CSF) Biomarkers do not Correlate with CSF Volumes or CSF Production Rate.
Edsbagge M; Andreasson U; Ambarki K; Wikkelsø C; Eklund A; Blennow K; Zetterberg H; Tullberg M
J Alzheimers Dis; 2017; 58(3):821-828. PubMed ID: 28505972
[TBL] [Abstract][Full Text] [Related]
11. Elevated CSF GAP-43 is Alzheimer's disease specific and associated with tau and amyloid pathology.
Sandelius Å; Portelius E; Källén Å; Zetterberg H; Rot U; Olsson B; Toledo JB; Shaw LM; Lee VMY; Irwin DJ; Grossman M; Weintraub D; Chen-Plotkin A; Wolk DA; McCluskey L; Elman L; Kostanjevecki V; Vandijck M; McBride J; Trojanowski JQ; Blennow K
Alzheimers Dement; 2019 Jan; 15(1):55-64. PubMed ID: 30321501
[TBL] [Abstract][Full Text] [Related]
12. Detection of tau proteins in normal and Alzheimer's disease cerebrospinal fluid with a sensitive sandwich enzyme-linked immunosorbent assay.
Vandermeeren M; Mercken M; Vanmechelen E; Six J; van de Voorde A; Martin JJ; Cras P
J Neurochem; 1993 Nov; 61(5):1828-34. PubMed ID: 8228996
[TBL] [Abstract][Full Text] [Related]
13. Neprilysin-like activity correlates with CSF-Tau and phospho-tau in patients with Alzheimer's disease.
Sorensen KC; Simonsen AH; Holmetoft UB; Hasselbalch SG; Heegaard NH
J Alzheimers Dis; 2013; 37(2):379-87. PubMed ID: 23948879
[TBL] [Abstract][Full Text] [Related]
14. Hyperphosphorylated tau protein in the cerebrospinal fluid of patients with Alzheimer's disease and other dementias: preliminary findings.
Hartmann AP; Almeida SM; Livramento JA; Nitrini R; Takahashi D; Caramelli P
Arq Neuropsiquiatr; 2004 Sep; 62(3B):751-5. PubMed ID: 15476062
[TBL] [Abstract][Full Text] [Related]
15. Tau in cerebrospinal fluid: a sensitive sandwich enzyme-linked immunosorbent assay using tyramide signal amplification.
Yamamori H; Khatoon S; Grundke-Iqbal I; Blennow K; Ewers M; Hampel H; Iqbal K
Neurosci Lett; 2007 May; 418(2):186-9. PubMed ID: 17400380
[TBL] [Abstract][Full Text] [Related]
16. Combined assessment of tau and neuronal thread protein in Alzheimer's disease CSF.
Kahle PJ; Jakowec M; Teipel SJ; Hampel H; Petzinger GM; Di Monte DA; Silverberg GD; Möller HJ; Yesavage JA; Tinklenberg JR; Shooter EM; Murphy GM
Neurology; 2000 Apr; 54(7):1498-504. PubMed ID: 10751266
[TBL] [Abstract][Full Text] [Related]
17. Inverse association of cortisol serum levels with T-tau, P-tau 181 and P-tau 231 peptide levels and T-tau/Abeta 1-42 ratios in CSF in patients with mild Alzheimer's disease dementia.
Laske C; Stransky E; Fritsche A; Eschweiler GW; Leyhe T
Eur Arch Psychiatry Clin Neurosci; 2009 Mar; 259(2):80-5. PubMed ID: 18806919
[TBL] [Abstract][Full Text] [Related]
18. Preclinical cerebrospinal fluid and volumetric magnetic resonance imaging biomarkers in Swedish familial Alzheimer's disease.
Thordardottir S; Ståhlbom AK; Ferreira D; Almkvist O; Westman E; Zetterberg H; Eriksdotter M; Blennow K; Graff C
J Alzheimers Dis; 2015; 43(4):1393-402. PubMed ID: 25182737
[TBL] [Abstract][Full Text] [Related]
19. Elevation of microtubule-associated protein tau in the cerebrospinal fluid of patients with Alzheimer's disease.
Vigo-Pelfrey C; Seubert P; Barbour R; Blomquist C; Lee M; Lee D; Coria F; Chang L; Miller B; Lieberburg I
Neurology; 1995 Apr; 45(4):788-93. PubMed ID: 7723971
[TBL] [Abstract][Full Text] [Related]
20. Increased total TAU but not amyloid-beta(42) in cerebrospinal fluid correlates with short-term memory impairment in Alzheimer's disease.
Lin YT; Cheng JT; Yao YC; Juo ; Lo YK; Lin CH; Ger LP; Lu PJ
J Alzheimers Dis; 2009; 18(4):907-18. PubMed ID: 19749420
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
